Half-year report · Q2

Period2025-01-01 → 2025-06-30
Filed2025-08-04
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥647m2025-01-01 → 2025-06-30Cons.Net sales
Revenue¥2.5bn2024-01-01 → 2024-12-31Cons.Net sales (5-year summary)
Revenue¥1.3bn2024-01-01 → 2024-06-30Cons.Net sales
Operating income−¥2.2bn2025-01-01 → 2025-06-30Cons.Operating income
Operating income−¥1.7bn2024-01-01 → 2024-06-30Cons.Operating income
Ordinary income−¥2.3bn2025-01-01 → 2025-06-30Cons.Ordinary income
Ordinary income−¥3.7bn2024-01-01 → 2024-12-31Cons.Ordinary income loss (5-year summary)
Ordinary income−¥1.5bn2024-01-01 → 2024-06-30Cons.Ordinary income
Profit before tax−¥2.4bn2025-01-01 → 2025-06-30Cons.Income before income taxes
Profit before tax−¥1.5bn2024-01-01 → 2024-06-30Cons.Income before income taxes
Net income (owners)−¥2.4bn2025-01-01 → 2025-06-30Cons.Profit loss attributable to owners of parent
Net income (owners)−¥3.8bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)−¥1.5bn2024-01-01 → 2024-06-30Cons.Profit loss attributable to owners of parent
Net income−¥2.4bn2025-01-01 → 2025-06-30Cons.Profit loss
Net income−¥1.5bn2024-01-01 → 2024-06-30Cons.Profit loss
Total assets¥4.1bnat 2025-06-30Cons.Assets
Total assets¥5.0bnat 2024-12-31Cons.Assets
Total assets¥7.2bnat 2024-06-30Cons.Total assets (5-year summary)
Total liabilities¥1.8bnat 2025-06-30Cons.Liabilities
Total liabilities¥771mat 2024-12-31Cons.Liabilities
Net assets / equity¥2.4bnat 2025-06-30Cons.Net assets
Net assets / equity¥4.2bnat 2024-12-31Cons.Net assets
Net assets / equity¥6.4bnat 2024-06-30Cons.Net assets (5-year summary)
Cash and deposits¥3.1bnat 2025-06-30Cons.Cash and deposits
Cash and deposits¥4.0bnat 2024-12-31Cons.Cash and deposits
Cash & equivalents¥3.1bnat 2025-06-30Cons.Cash and cash equivalents
Cash & equivalents¥4.0bnat 2024-12-31Cons.Cash and cash equivalents
Cash & equivalents¥6.4bnat 2024-06-30Cons.Cash and cash equivalents
Cash & equivalents¥6.5bnat 2023-12-31vCons.Cash and cash equivalents
Operating cash flow−¥2.5bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in operating activities
Operating cash flow−¥3.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥1.1bn2024-01-01 → 2024-06-30Cons.Net cash provided by used in operating activities
Investing cash flow¥7m2025-01-01 → 2025-06-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥4m2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow¥25m2024-01-01 → 2024-06-30Cons.Net cash provided by used in investment activities
Financing cash flow¥1.7bn2025-01-01 → 2025-06-30Cons.Net cash provided by used in financing activities
Financing cash flow¥708m2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥723m2024-01-01 → 2024-06-30Cons.Net cash provided by used in financing activities
EPS (basic)¥-49.352025-01-01 → 2025-06-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-852024-01-01 → 2024-12-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥-34.752024-01-01 → 2024-06-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio48.8%at 2025-06-30Cons.Equity to asset ratio (5-year summary)
Equity ratio78.1%at 2024-12-31Cons.Equity to asset ratio (5-year summary)
Equity ratio85.0%at 2024-06-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

All source rows · 432
ItemContextValueUnit
Proceeds from disposal of treasury stock fin cfPrior1YTDDuration8000JPY
Proceeds from disposal of treasury stock fin cfCurrentYTDDuration-JPY
Net cash provided by used in financing activitiesPrior1YTDDuration723367000JPY
Net cash provided by used in financing activitiesCurrentYTDDuration1703651000JPY
Effect of exchange rate change on cash and cash equivalentsPrior1YTDDuration228184000JPY
Effect of exchange rate change on cash and cash equivalentsCurrentYTDDuration-109315000JPY
Net increase decrease in cash and cash equivalentsPrior1YTDDuration-158295000JPY
Net increase decrease in cash and cash equivalentsCurrentYTDDuration-909732000JPY
Cash and cash equivalentsPrior2YearInstant6517007000JPY
Cash and cash equivalentsPrior1YearInstant3963580000JPY
Cash and cash equivalentsPrior1QuarterInstant6358711000JPY
Cash and cash equivalentsCurrentQuarterInstant3053848000JPY
Promotion expenses sgaPrior1YTDDuration372389000JPY
Promotion expenses sgaCurrentYTDDuration281033000JPY
Directors compensations sgaPrior1YTDDuration75959000JPY
Directors compensations sgaCurrentYTDDuration84184000JPY
Payroll and allowances sgaPrior1YTDDuration210570000JPY
Payroll and allowances sgaCurrentYTDDuration262626000JPY
Retirement benefit expenses sgaPrior1YTDDuration305000JPY
Retirement benefit expenses sgaCurrentYTDDuration224000JPY
Research and development expenses sgaPrior1YTDDuration1531833000JPY
Research and development expenses sgaCurrentYTDDuration1581890000JPY
Document title cover pageFilingDateInstant
Original text (Japanese)半期報告書
Clause of stipulation cover pageFilingDateInstant
Original text (Japanese)金融商品取引法第24条の5第1項の表の第1号
Place of filing cover pageFilingDateInstant
Original text (Japanese)関東財務局長
Filing date cover pageFilingDateInstant2025-08-04
Quarterly accounting period cover pageFilingDateInstant
Original text (Japanese)第21期中(自 2025年1月1日 至 2025年6月30日)
Company name cover pageFilingDateInstant
Original text (Japanese)シンバイオ製薬株式会社
Company name in english cover pageFilingDateInstantSymBio Pharmaceuticals Limited
Title and name of representative cover pageFilingDateInstant
Original text (Japanese)代表取締役社長兼CEO  吉田 文紀
Address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目1番28号
Telephone number address of registered headquarter cover pageFilingDateInstant03(5472)1125
Name of contact person address of registered headquarter cover pageFilingDateInstant
Original text (Japanese)経理部長  湊 裕史
Nearest place of contact cover pageFilingDateInstant
Original text (Japanese)東京都港区虎ノ門四丁目1番28号
Telephone number nearest place of contact cover pageFilingDateInstant03(5472)1125
Name of contact person nearest place of contact cover pageFilingDateInstant
Original text (Japanese)経理部長  湊 裕史
Place for public inspection cover page (text)FilingDateInstantText · Plus
Edinet codeFilingDateInstantE24682
Fund codeFilingDateInstant-
Security codeFilingDateInstant45820
Filer name in japaneseFilingDateInstant
Original text (Japanese)シンバイオ製薬株式会社
Filer name in englishFilingDateInstantSymBio Pharmaceuticals Limited
Fund name in japaneseFilingDateInstant-
Fund name in englishFilingDateInstant-
Cabinet office ordinanceFilingDateInstant
Original text (Japanese)企業内容等の開示に関する内閣府令
Document typeFilingDateInstant
Original text (Japanese)第四号の三様式
Accounting standardsFilingDateInstantJapan GAAP
Whether consolidated financial statements are preparedFilingDateInstanttrue
Industry code when consolidated financial statements are prepared in accordance with industry specific regulationsFilingDateInstantcte
Industry code when financial statements are prepared in accordance with industry specific regulationsFilingDateInstant-

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identityconsolidated 2025-06-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2024-12-31pass
statement vs summary · net assetsconsolidated 2025-06-30pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-06-30pass
statement vs summary · net income attributable to parentconsolidated 2025-01-01/2025-06-30pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-06-30pass
statement vs summary · operating cash flowconsolidated 2025-01-01/2025-06-30pass
statement vs summary · revenueconsolidated 2024-01-01/2024-06-30pass
statement vs summary · revenueconsolidated 2025-01-01/2025-06-30pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsconsolidated 2025-06-30pass